Patent · US Active

Stabilized protein crystals, formulations comprising them and methods of making them

US8558048B2 · kind B2 · utility

1Cited by
45References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 30, 2009
Grant dateOct 15, 2013
Priority date
Expiry dateMar 21, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/815
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to methods for the stabilization, storage and delivery of biologically active macromolecules, such as proteins, peptides and nucleic acids. In particular, this invention relates to protein or nucleic acid crystals, formulations and compositions comprising them. Methods are provided for the crystallization of proteins and nucleic acids and for the preparation of stabilized protein or nucleic acid crystals for use in dry or slurry formulations. The present invention is further directed to encapsulating proteins, glycoproteins, enzymes, antibodies, hormones and peptide crystals or crystal formulations into compositions for biological delivery to humans and animals. According to this invention, protein crystals or crystal formulations are encapsulated within a matrix comprising a polymeric carrier to form a composition. The formulations and compositions enhance preservation of the native biologically active tertiary structure of the proteins and create a reservoir which can slowly release active protein where and when it is needed. Methods are provided preparing stabilized formulations using pharmaceutical ingredients or excipients and optionally encapsulating th…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.